Thus, the role of DSC2 seems to be entity-specific, or even subtype-specific, as shown in our study with a clear negative prognostic value of DSC2 in HER2 positive and TNBC, yet no impact on survival for patients with luminal breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.